Home Use of Mini-Dose Glucagon As a Novel Treatment for Hypoglycemia Following Repeated, Prolonged Fasts in Type 1 Diabetes During Ramadan

OBJECTIVE: We determined the efficacy of self-administered subcutaneous mini-dose glucagon (MDG) to treat fasting-induced hypoglycemia in type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: This was a 4-week randomized, controlled crossover trial of 2-week MDG or 2-week oral glucose tablets (OG, con...

Descripción completa

Detalles Bibliográficos
Autores principales: Algeffari, Metab, Hussain, Sufyan, Almogbel, Turki, Alsharidah, Mansour, Alghadouni, Habibah, Mahmood, Farid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2022
Materias:
Novel Communications in Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016730/
https://www.ncbi.nlm.nih.gov/pubmed/35176134
http://dx.doi.org/10.2337/dc21-1655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016730/
https://www.ncbi.nlm.nih.gov/pubmed/35176134
http://dx.doi.org/10.2337/dc21-1655

Ejemplares similares